Corrigendum to 'Secoisolariciresinol diglucoside inhibits adipogenesis through the AMPK pathway' [European Journal of Pharmacology (2018) 820:235-244]
- PMID: 29784189
- DOI: 10.1016/j.ejphar.2018.05.012
Corrigendum to 'Secoisolariciresinol diglucoside inhibits adipogenesis through the AMPK pathway' [European Journal of Pharmacology (2018) 820:235-244]
Erratum for
-
Secoisolariciresinol diglucoside inhibits adipogenesis through the AMPK pathway.Eur J Pharmacol. 2018 Feb 5;820:235-244. doi: 10.1016/j.ejphar.2017.12.038. Epub 2017 Dec 18. Eur J Pharmacol. 2018. PMID: 29269018
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources